跳至主要内容
临床试验/NCT01225198
NCT01225198已完成2 期

New Vitamin/Mineral Supplement for Children and Adults With Autism - National Study

Arizona State University1 个研究点 分布在 1 个国家目标入组 143 人开始时间: 2008年5月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
143
试验地点
1
主要终点
Oxidative Stress

研究概览

简要总结

The investigators hypothesis is that a new, revised formulation of a vitamin/mineral supplement will result in:

  1. improvement of nutritional status in some children/adults with autism, and
  2. reduction of some of the symptoms of autism in some children

详细描述

The major goal of this study is to determine the effect of this vitamin/mineral supplement on levels of vitamins, minerals, neurotransmitters, and biomarkers for nutritional deficiencies. The study design is a randomized, double-blind, placebo-controlled. Blood and urine measurements will be measured at the beginning of the study in children with autism and typical children. Then, the children with autism will be given the supplement or placebo for 12 weeks, and then their blood and urine will be re-measured.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
3 Years 至 60 Years(Child, Adult)
性别
All
接受健康志愿者
是

入选标准

  • •age 3-60 years old;
  • •Autism Group: diagnosis of autism, pervasive developmental disorder/not otherwise specified (PDD/NOS), or Asperger's by a psychiatrist or similar professional
  • •Control Group: in good mental and physical health, and no siblings with autism spectrum disorders, and no evidence of Attention Deficit Disorder by parent report

排除标准

  • •Usage of a vitamin/mineral supplement in the last 2 months
  • •Current use of any chelation treatment

研究组 & 干预措施

Placebo Group

Placebo Comparator

Liquid placebo with identical packaging and flavoring to the real supplement.

干预措施: Liquid Placebo (Other)

Vitamin/Mineral Supplement Group

Experimental

Multi-vitamin/mineral supplement designed for this study for children and adults with autism spectrum disorders.

干预措施: Multi-Vitamin/Mineral Supplement (Dietary Supplement)

结局指标

主要结局

Oxidative Stress

时间窗: End of Study (after 12 weeks of treatment)

Level of plasma nitrotyrosine

Oxidative Stress

时间窗: Beginning of study (day 0)

Level of Plasma Nitrotyrosine

次要结局

  • Parent Global Impressions - Revised(End of study (12 weeks))

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验